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Abstract
Background: Protein quality control mechanisms are essential for cell health and involve delivery of proteins to
specific cellular compartments for recycling or degradation. In particular, stray hydrophobic proteins are captured in
the aqueous cytosol by a co-chaperone, the small glutamine-rich, tetratricopeptide repeat-containing protein alpha
(SGTA), which facilitates the correct targeting of tail-anchored membrane proteins, as well as the sorting of membrane
and secretory proteins that mislocalize to the cytosol and endoplasmic reticulum-associated degradation. Full-length
SGTA has an unusual elongated dimeric structure that has, until now, evaded detailed structural analysis. The C-
terminal region of SGTA plays a key role in binding a broad range of hydrophobic substrates, yet in contrast to the
well-characterized N-terminal and TPR domains, there is a lack of structural information on the C-terminal domain. In
this study, we present new insights into the conformation and organization of distinct domains of SGTA and show that
the C-terminal domain possesses a conserved region essential for substrate processing in vivo.
Results: We show that the C-terminal domain region is characterized by α-helical propensity and an intrinsic ability to
dimerize independently of the N-terminal domain. Based on the properties of different regions of SGTA that
are revealed using cell biology, NMR, SAXS, Native MS, and EPR, we observe that its C-terminal domain can
dimerize in the full-length protein and propose that this reflects a closed conformation of the substrate-binding domain.
Conclusion: Our results provide novel insights into the structural complexity of SGTA and provide a new basis
for mechanistic studies of substrate binding and release at the C-terminal region.
Introduction
Homo- and hetero-multimerization of proteins can confer
many benefits on a system including orientating different
binding partners into suitable proximity, increasing local
concentrations of reactants, and capturing substrates with
tweezer- or scissor-like actions [1]. Multimerization is par-
ticularly useful in mechanisms that rely on cascades of
transient, low affinity interactions, such as the collabor-
ation between co-chaperone SGTA (small glutamine-rich,
tetratricopeptide repeat-containing protein alpha) and the
BAG6 complex [2], which regulates the fate of hydropho-
bic proteins exposed to the aqueous environment of the
cytoplasm in cells (summarized in Fig. 1). These substrates
include misfolded or mislocalized membrane and
secretory proteins (MLPs) [3] that are ultimately destined
for proteasomal degradation and tail-anchored (TA)
proteins that are en route for TRC40-mediated targeting
to the ER. In the case of TA proteins, the C-terminal loca-
tion of their ER targeting signal necessitates a post-transla-
tional delivery mechanism [4].
The heterotrimeric BAG6 complex is thought to be
composed of a dimer or multimer of heterotrimers [5],
each comprising one copy of BAG6 (BCL2-associated
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athanogene 6), TRC35 (transmembrane recognition
complex 35), and UBL4A (ubiquitin-like protein 4A).
BAG6, for which limited structural information exists, is
a 119 kDa protein whose oligomerization is not yet well
defined [6]. The non-canonical “BAG domain” region
close to the C-terminus of BAG6 is, however, known
to bind directly to a C-terminal region of UBL4A with
crystal structures of the minimal complex solved [5,
7]. Similarly, a C-terminal stretch of BAG6, adjacent
to the “BAG domain” interacts with the C-terminal
domain of TRC35 [3].
The ability of SGTA to interact with the BAG6 complex
and a common cohort of hydrophobic substrates enables
it to transfer selected protein clients onto the BAG6 com-
plex for sorting and triage [8, 9]. Potential outcomes may
include refolding to a native conformation, targeting to
the correct subcellular destination or selective degradation
[10–13]. Hence, hydrophobic substrates, such as MLPs,
bound to the BAG6 complex can be ubiquitinated by the
E3 ligase, RNF126, and targeted for proteasomal degrad-
ation [14, 15]. It is proposed that SGTA can promote sub-
strate deubiquitination, thereby delaying the, normally
efficient, degradation of such MLPs and antagonizing the
actions of the BAG6 complex [10, 13]. Furthermore, re-
cent studies show that the perturbations of MLP quality
control observed upon SGTA overexpression require the
binding of its central TPR domain to the intrinsic protea-
somal ubiquitin receptor Rpn13 [12, 16].
One well-established role of SGTA is the post-transla-
tional targeting of TA proteins to the endoplasmic
reticulum (ER) for membrane insertion. Acting as a
co-chaperone for the BAG6 complex, SGTA facilitates
the transfer of newly synthesized TA proteins to the
downstream targeting factor TRC40, also a homodimer
but with well-characterized “open” and “closed” states
that are regulated via its ATP hydrolysis cycle [17, 18].
Fig. 1 Roles of SGTA in cytoplasmic quality control. SGTA binds to hydrophobic substrates (MLPs or TMDs of TA proteins) via its C-terminal
domain (1). It collaborates with the BAG6 complex (composed of BAG6, TRC35, and UBL4A) which interacts with SGTA through its UBL domains
(2). Hydrophobic substrates bound to the BAG6 complex can be ubiquitinated by E3 ligase RNF126 (3) and targeted for degradation via the UPS
(4). SGTA TPR domain interacts with the proteasomal subunit RPN13. SGTA shields exposed hydrophobic regions on TA proteins en route to ER
membrane insertion, handing them on to the downstream TRC40 targeting complex (5)
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TRC40 interacts with C-terminal hydrophobic regions of
TA proteins [7, 19] and promotes their delivery to and
insertion into the ER membrane via a heterodimeric
membrane protein receptor composed of the WRB and
CAML proteins [20–22].
SGTA is a structurally unusual homodimer [23] with
each 34 kDa monomer consisting of three structurally
distinct domains that have interconnected functions.
The structure of the N-terminal dimerization domain
has been extensively characterized [8, 9, 24] providing
insights into its role in TA membrane protein insertion
and its interaction with the BAG6 complex in MLP
quality control pathways. This region can bind to two
different ubiquitin-like domains (UBLs) that are dis-
played by the BAG6 complex, which constitute the
N-terminal domains of both the UBL4A and BAG6 sub-
units. The central region of SGTA is the most conserved
domain, consisting of three, almost identical, tetratrico-
peptide repeats (TPRs) arranged in tandem, each formed
by a pair of α-helices folded in an antiparallel fashion
[25]. The structure of the SGTA TPR domain was deter-
mined previously by X-ray crystallography, and its three
TPRs are followed by a C-terminal capping helix [25].
This domain has also been reported to interact directly
with Hsp70 and Hsp90 chaperones [2, 26] and the pro-
teasomal subunit Rpn13 [12, 27]. The TPR domain has
also been linked to viral replication and hormone recep-
tor signaling, with implications for both health and dis-
ease [28, 29]. The C-terminal substrate-binding domain
of SGTA contains a glutamine-rich stretch [30] and is
known to bind hydrophobic substrates [31] but its struc-
ture is, as yet, completely undetermined.
Studies of the C-terminal domain of SGTA have thus
far focused on the glutamine-rich region, and the role of
the well-conserved remainder has not yet been explored
[30]. In this work, we identify a region of the SGTA
C-terminal domain that alters its impact on MLP quality
control. Moreover, via an integrated biophysical analysis,
we explore the structural and dynamic properties of
full-length SGTA in vitro. We demonstrate that the
C-terminal domain can exist in solution as a dimer, and
provide the first evidence that SGTA exhibits a
C-terminally “closed” conformation stabilized by an
NNP region that is important for the efficient processing
of mislocalized proteins.
Results
The NNP region in the C-terminal domain contributes to
SGTA function
Based on sequence homology (Fig. 2a and Additional file 1:
Figure S1), we propose that SGTA contains four
well-defined regions of conservation: the first two regions
match the widely studied N-terminal and TPR domains,
respectively, while we have sub-divided the remaining
C-terminal section in two: a region characterized by three
repetitions of a NNP motif (that we call the NNP region),
followed by a separate glutamine-rich stretch (Q-rich re-
gion) (Fig. 2a). While the Q-rich region has previously
been implicated in binding hydrophobic substrates [30],
the potential role of the NNP motifs has not been ad-
dressed. We therefore prepared a mutant version of
SGTA-V5 [13] in which all three NNP motifs were altered
to triple alanines (SGTA-3xNNP/AAA-V5), together with
a truncated form of SGTA that retained the NNP motifs
but lacked the Q-rich region (SGTA-ΔQ-V5; see Fig. 2b).
SGTA participates in the selective quality control of
mislocalized membrane proteins (MLPs) that have failed
to reach the endoplasmic reticulum (ER) and defaulted
to the cytosol [12, 13, 32]. The overexpression of ex-
ogenous SGTA can lead to an increase in the
steady-state level of such MLPs, most likely by perturb-
ing their otherwise efficient proteasomal degradation
[13, 33]. We therefore asked how the mutation of the
NNP motifs and loss of the Q-rich region affected the
steady-state level of OP91, an N-terminal fragment of
the polytopic integral membrane protein opsin, which
acts as a model MLP in cultured mammalian cells [13,
27]. When SGTA-3xNNP/AAA-V5 was overexpressed in
HeLa cells induced to produce OP91, a clear increase in
the amount of cytosolic, non-glycosylated, OP91 was
seen as compared to the expression of a PEX19 control
(Fig. 2c). This > 20 fold increase was well above the ~ 5
fold increase seen with full-length SGTA-V5 [12] (Fig. 2c,
d). In contrast, the normalized effect of SGTA-ΔQ-V5
co-expression on OP91 levels was comparable to that
observed using SGTA-V5 (Fig. 2d) indicating that delet-
ing just the Q-rich region had no measurable effect.
In addition to enhancing the steady-state level of
model MLPs including OP91, the co-expression of ex-
ogenous SGTA-V5 results in the appearance of discrete
cytosolic inclusions that contain both SGTA and model
MLP substrates [13]. We therefore transiently expressed
SGTA variants, or the PEX19 control, in HeLa cells in-
duced to make OP91 and analyzed them by immuno-
fluorescence microscopy. In agreement with the increase
in steady-state OP91 levels (Fig. 2c, d), the number of
intracellular inclusions that contain OP91 was greater in
the presence of the SGTA-3xNNP/AAA-V5 mutant as
compared to wild-type SGTA-V5 (Fig. 2e, f and
Additional file 2: Figure S2). In contrast, the previously
described SGTA TPR mutant [12], which is unable to
interact with chaperones or the proteasome, showed a
clear reduction in the number of intracellular OP91
containing inclusions (Fig. 2f and Additional file 2:
Figure S2), while the effect of the SGTA-ΔQ-V5
mutant was not statistically significant (Fig. 2f and
Additional file 2: Figure S2). Quantification revealed
that the number of cells containing large perinuclear
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Fig. 2 Mutations in SGTA NNP region enhance the steady state of a model MLP and promote its accumulation in cytoplasmic inclusions. a Schematic
representation of SGTA domain organization alongside a sequence alignment (purple indicates high conservation; expanded version of the alignment is
shown in Additional file 1: Figure S1). b Summary of all SGTA-V5 variants designed for this part of the work. c HeLa cells stably expressing OP91 under an
inducible promoter were transiently transfected with plasmids encoding either a control (PEX19-V5) or V5-tagged SGTA variants as indicated, and
OP91 expression induced. The resulting levels of OP91 and exogenous PEX19/SGTA variants were visualized via Western blotting and fluorescence
based detection (LI-COR). d Quantified signals for PEX19-V5 or SGTA-V5 species were normalized to endogenous tubulin, which acted as a loading
control and the OP91 levels then expressed relative to the respective normalized V5 signal, with the ratio for OP91/PEX19-V5 set as one. Values show
means ± s.e.m. from three independent technical repeats; P was determined by a Student’s t test. e HeLa cells stably expressing OP91 were
co-transfected as in (c), the cells fixed, and then labeled for immunofluorescence microscopy using antibodies that recognize either OP91 or
the V5 tag on PEX19 and the SGTA variants. Scale bar is 10 μm (see also Additional file 2: Figure S2). f The percentage of cells displaying opsin-positive
inclusions were counted from the experiments described in (e) (n≥ 100 cells/condition from total of three experiments). Error bars show s.e.m., and P
is determined by a Student’s t test
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inclusions was threefold greater in the presence of
SGTA-3xNNP/AAA-V5 than SGTA-V5 (Fig. 2f ).
Interestingly, although exogenous SGTA-V5 only en-
ters cytosolic inclusions in the presence of an MLP
substrate (Additional file 3: Figure S3), as previously
reported [13], the SGTA-3xNNP/AAA-V5 variant
can form these structures in the absence of OP91 in-
duction (Additional file 3: Figure S3). On the basis
of these findings, we concluded that the NNP motifs
in the C-terminal region of SGTA make a distinct
contribution to its cellular function and set out to
determine their structural significance.
The C-terminal domain of SGTA is a partially folded
region with the ability to dimerize
Having demonstrated that the conserved NNP region at
the C-terminus of SGTA contributes to its cellular func-
tion(s), we performed structural and biophysical studies
to better define this domain. In the first instance, we
produced both the complete C-terminal domain (CT;
residues 213–313) and a version lacking the Q-rich re-
gion (CTΔQ; residues 213–274). Circular dichroism
(CD) analysis of both fragments in the far UV region of
the spectra showed characteristic α-helical minima of
elipticity at 208 and 222 nm and a maximum around
190 nm, features that were also retained in the CT con-
struct in which the three NNP motifs were mutated to
AAA (Fig. 3a). A deconvolution analysis of the spectra
showed around 46 and 36% of α-helical secondary struc-
ture for the CT and the CTΔQ proteins, respectively.
The NMR 1H-15N HSQC spectrum of the C-terminal
domain showed poor peak dispersion which is character-
istic of unfolded protein (Fig. 3b). Despite the extensive
optimization of buffer, temperature and pH conditions
(see the “Methods” section and Additional file 4: Figure
S4), we were unable to complete the backbone assign-
ment (BMRB accession number: 27272) due to a severe
line broadening effect present in two regions of the se-
quence representing ~ 20 residues in the NNP area and
~ 30 residues in the Q-rich region. The CTΔQ version
presented identical problems for the same NNP residues
(Additional file 5: Figure S5). Chemical shift index (CSI)
analysis (Cα, Cβ, and CO) of the assignable regions pre-
dominantly indicated random coil except for those resi-
dues immediately surrounding the missing regions,
which presented α-helical propensity (Additional file 6:
Figure S6) suggesting that the unassigned regions ac-
count for the helical content observed by CD.
The C-terminal domain of SGTA showed a tendency
to aggregate, eluting far earlier than expected in
size-exclusion chromatography and displaying aggrega-
tion propensity in dynamic light scattering (DLS) experi-
ments (Additional file 7: Figure S7). In addition, we have
observed that protein samples at high concentration
undergo a phase transition from solution to hydrogel.
In order to further investigate its oligomerisation state,
we performed native mass spectrometry experiments on
the SGTA CT protein. Surprisingly we found that the
major species present in solution is a dimer (Fig. 3c).
When these data were analyzed in more detail, we de-
tected different forms of the C-terminal dimer that vary
in molecular weight by multiples of 359 ± 23 Da. We
have discounted covalent modifications of the protein by
performing mass spectrometry on the same protein in
denaturing conditions, which no longer exhibits this
additional mass (Additional file 8: Figure S8). We con-
clude that these larger species most likely correspond to
a non-covalently bound molecule present at a stoichiom-
etry of between one and four times that of the SGTA
C-terminal region. Because the C-terminal region of
SGTA is proposed to recognize hydrophobic substrates
[30], we speculate that this molecule might be a bacterial
lipid or hydrophobic tripeptide derived from the recom-
binant expression in Escherichia coli. However, all our
attempts to identify this molecule have thus far proved
inconclusive.
To mimic our biological experiments, we performed
equivalent MS on the C-terminal 3xNNP/AAA mutant.
In this case, the major species was the monomer with a
minor representation of aggregated states and no add-
itional mass was present (Fig. 3d). The propensity of this
mutant to aggregate was also observed in analytic SEC
(Additional file 7: Figure S7C). We conclude that mutat-
ing the NNP region in this way strongly destabilizes the
C-terminal dimerization.
SGTA domains behave as structurally independent units
Having established that the C-terminal region of SGTA
is able to dimerize when expressed as an excised poly-
peptide, we wondered how such an interaction would
affect the overall domain arrangement of SGTA. We ac-
quired a set of 1H-15N HSQC spectra for a series of
SGTA-derived polypeptides (Fig. 4a, b) representing a
wide range of domain combinations, under identical
conditions. For the proteins containing the Q-rich re-
gion of SGTA (FL and CT; Fig. 4a), deuteration was re-
quired because of a major peak broadening effect
probably due to the C-terminal aggregation tendency.
All construct spectra were assigned using some previ-
ously obtained data (BMRB accession numbers: 19779
and 5709) and additional 3D backbone experiments (see
the “Methods” section). We achieved 84% total backbone
assignments for FL SGTA with only the aforementioned
missing NNP and Q-rich regions left unassigned (CT,
TPR-CTΔQ, and NT assignments were deposited as
BMRB accession numbers: 27272, 27275 and 27276,
respectively).
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The HSQC spectral comparison shows that the fold of
each domain is maintained across all constructs analyzed
(Fig. 4b and Additional file 5: Figure S5); hence, almost
no change is observed upon chemical shift value analysis
for each amino acid, except in the boundary regions
between the domains (Fig. 4c and Additional file 9: Fig-
ure S9). These results suggest that each domain is
structurally independent of the presence of the rest of
the protein and that there are minimal inter-domain
contacts. They also indicate that the C-terminal
dimerization, if it occurs in the longer constructs, is not
perturbing the chemical shift values of the rest of the
protein. The chemical shift differences between the CT
and CTΔQ constructs (Additional file 8: Figure S8) are
a b
c d
Fig. 3 Biophysical characterization of SGTA C-terminal domain. a Far UV CD spectra of the C-terminal domain of SGTA (top), its version lacking
the glutamine-rich region (middle) and the C-terminal mutated in the NNP region (bottom). b 1H-15N TROSY HSQC of the deuterated version of
SGTA C-terminal domain with partial assignment. c, d Native mass spectrometry spectra of the C-terminal domain of SGTA (c) and of the SGTA
3xNNP/AAA C-terminal mutant (d). Peaks corresponding to the same species are marked with colored circles with the charge number written
inside. The theoretical molecular weight appears under the title and the obtained molecular weights for each species are shown on the right in
the same color scheme
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more significant than in all the other comparisons and
extend beyond the residues close to the truncation point.
This points to stabilizing interactions between the
Q-rich region and the rest of the C-terminal domain.
Finally, we used 15N - {1H} heteronuclear NOE mea-
surements of the different SGTA derivatives to address
the motion of NH vectors for each amino acid (Fig. 4d
and Additional file 10: Figure S10). The results con-
firmed the previously defined folded domains and un-
structured linkers of the N-terminal dimerization and
TPR domains. Beyond the TPR domain, the majority of
heteronuclear NOE values are typical of flexible polypep-
tide, but those obtained for residues surrounding the un-
assigned NNP and Q-rich regions are somewhat higher,
suggesting that the missing parts tend towards a more
ordered arrangement, consistent with our idea that they
form α-helices (Additional file 5: Figure S5).
A closed conformation for the full-length SGTA dimer
Having identified dimerization of the SGTA C-terminal
region, and knowing that all domains are structurally in-
dependent entities, we employed four complementary
a b
c
d
Fig. 4 NMR analysis of SGTA constructs. a Cartoon representation of the different SGTA variants used for NMR comparison. b Overlaid 1H-15N
HSQC spectra of FL SGTA (black), NT (blue), TPR (red), and CT (green) constructs. c Chemical shift difference analysis of amide signals from N-
terminal, TPR, and C-terminal region in the single domain context versus FL SGTA. d 15N - {1H} heteronuclear NOE measurements for FL SGTA
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experiments to explore the possibility that this may
reflect a “closed conformation” in dimeric, full-length
SGTA.
First, using native mass spectrometry, we confirmed
that the longer constructs of SGTA containing the
N-terminal dimerisation domain are indeed dimers. The
results for the NT-TPR, FLΔQ, and FL versions of SGTA
clearly showed the dimer as the major species present in
solution (Fig. 5). A detailed analysis of the spectra ob-
tained from FL SGTA, again revealed the presence of
different variants of the dimer with one to four copies of
a similar small molecule bound to it (370 ± 15 Da). This
behavior imitates that of the excised C-terminal dimer
and was our first indication that the properties we ob-
serve with this truncated fragment of SGTA also apply
to the full-length protein. Surprisingly, in the construct
lacking the Q-rich region, no additional mass was ob-
served suggesting that this region is necessary for bind-
ing the presumptive small molecules.
Next, we performed SAXS on full-length SGTA (FL;
SASBDB accession number: SASDDB6) and the version
lacking the C-terminal domain (NT-TPR variant;
SASBDB accession number: SASDDC6) to test whether
a possible C-terminal dimerization might constrain the
central TPR domain within full-length SGTA. Parame-
ters including the values for radius of gyration (Rg), max-
imum linear dimension (Dmax), hydrated particle volume
(VP), and the molecular weight (MW) of the individual
constructs are summarized in Table 1. The estimated
molecular mass and hydrated particle volume for both
proteins indicate that, as expected, they are in a dimeric
state (Table 1 and Additional file 11: Table S1), and the
peaks in the distance distribution function (Fig. 5b) con-
firm the presence of multiple domains. The first peak, at
about 3 nm, corresponds to distances inside the individ-
ual domains, while the second peak, at about 5 nm, cor-
responds to the inter-domain distance. The fact that this
second peak is maintained and becomes even more ac-
centuated with FL SGTA as compared to NT-TPR indi-
cates that the full-length protein adopts a more compact
overall conformation in solution.
The Kratky plots generated from both SGTA con-
structs show a composite peak structure in the region
0.07–2 nm−1, as expected from multi-domain proteins.
For s > 2 nm−1 the Kratky plot tends to a plateau, giving
a qualitative indication of moderate flexibility for all the
constructs measured. This result is compatible with the
presence of flexible portions in both the NT-TPR region
and the C-terminal domain (Fig. 5b).
We have also applied an ensemble optimization
method (EOM), in order to fit the data in a way that al-
lows for ensembles of possible conformations that may
co-exist in solution. In this method, an ensemble of 50
structures is selected to fit the scattering data from a
large pool of 10,000 randomized structures. The pool
was generated by using the high-resolution structures of
N-terminal and TPR domain (4CPG [9] and 2VYI [25]
PDB entries, respectively), which are treated as rigid
bodies, and modeling the missing portions as dummy
residues in random conformations. The results of this
EOM approach (Fig. 5b) show that for full-length SGTA,
the selected ensemble presents a much lower radius of
gyration (Rg) than the average of the structures in the
pool, while for the SGTA NT-TPR construct, the se-
lected ensemble has a similar averaged Rg to that of the
pool. This suggests that, in comparison to the NT-TPR
region, flexibility is reduced in full-length SGTA, where
only a subset of compact conformations fits the data, a
situation compatible with a C-terminally closed con-
formation for SGTA.
To further corroborate the presence of C-terminal
dimerization in the full-length version of SGTA, we
studied the NMR relaxation parameters of N-terminal
and TPR domains in the context of the different SGTA
constructs. We measured the T1 and T2 relaxation
values and the correlation time (τc) for each domain in
NT, TPR, NT-TPR, TPR-CTΔQ, and FL SGTA
(Additional file 12: Figure S11). Data show that the
N-terminal dimerization domain has similar correlation
time values (10–11 ns) in all contexts. However, while
the correlation time for the TPR domain is similar in the
TPR, TPR-CTΔQ and NT-TPR contexts (9–10 ns), the
value rises to 12 ns when it is situated within full-length
SGTA (Fig. 6a). It should be noted that our correlation
time calculations were performed using an isotropic
model (due to the impossibility of providing accurate
anisotropy parameters from the limited structural infor-
mation available to us). They hence represent an over-
simplification but, nonetheless, a useful way to compare
the variants. The same trend was observed by comparing
1H-15N HSQC spectra of the different constructs. Hence,
while TPR signals suffer a dramatic line broadening ef-
fect in FLΔQ and FL SGTA, the corresponding effect on
the N-terminal signals is far less severe (Fig. 6b). These
NMR data show that the dynamic parameters of the
TPR domain vary depending on whether it is located at
one end (N or C) of the protein (TPR, TPR-CTΔQ,
NT-TPR constructs) versus being flanked by additional
regions on either side (FLΔQ and FL constructs).
Finally, the role of the C-terminal domain in the
dimerisation of SGTA was assessed using double
electron-electron resonance (DEER) spectroscopy. Four
carefully chosen positions were independently labeled
along the length of the TPR domain (S88C, S136C,
C153, and S197C; Additional file 13: Figure S12) and
distances were measured between homologous sites in
each monomer in the NT-TPR and FL proteins. Success-
ful labeling was confirmed by continuous-wave (CW)
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EPR spectroscopy (Additional file 14: Figure S13). The
room temperature CW spectra of FL SGTA S88C, C153,
and S197C variants reveal relatively mobile spin labels
that are thus solvent exposed. In contrast, S136C shows
low mobility and is likely constrained by its location in-
side the TPR groove (Additional file 13: Figure S12). In
all cases, deletion of the C-terminus results in slightly
greater mobility of the spin labels (Additional file 14:
Figure S13) probably due to the contribution of the
b
a
Fig. 5 SGTA C-terminal domain is able to dimerise in the full-length context I. a Native mass spectrometry chromatograms of the SGTA FL protein
(left) and the NT-TPR (upright) and FLΔQ (downright) constructs. Peaks corresponding to the same species are marked with colored circles with the
charge number written inside. The theoretical molecular weight appears under the title and the obtained molecular weights for each species are
shown on the right following the corresponding color. b SAXS analysis of SGTA FL (red) and NT-TPR (green) proteins: distance distribution plot (top
left), Kratky plot (top right) and ensemble optimization method analysis data (bottom)
Table 1 Overall parameters estimated from SAXS data: the
molecular weight (MW) for each SGTA construct is compared with
the expected value for the corresponding dimeric assembly. We
report the values of radius of gyration (Rg), the maximum linear
dimension (Dmax), and the Porod volume (VP) calculated by the
program GNOM
Sample MW (kDa) expt. MW (kDa) Rg (nm) Dmax (nm) VP (nm
3)
NT-TPR 41 ± 4 47 3.6 ± 0.1 14 ± 1 66 ± 1
FL 65 ± 5 68 4.2 ± 0.2 18 ± 1 168 ± 2
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faster tumbling of the TPR in the absence of the
C-terminal domain.
Comparing the DEER traces and corresponding dis-
tances for full-length SGTA versus the respective
C-terminal deletion mutants (Fig. 6c and Additional file 15:
Figure S14), we found that in the full-length protein all
four mutants show a similar bimodal distance distribution
with a broad set of distances centered around 5 nm and a
sharp peak at ca. 7 nm. We conclude that this heterogen-
eity reflects the presence of flexible linkers that connect
the central TPR region to the N- and C-terminal domains
of the protein, resulting in a diverse population of
conformations.
Deletion of the C-terminal domain has different effects
depending on the probe location that is being consid-
ered. For S88C, C-terminal deletion has little effect, as
expected for a site close to the tight dimerization of the
N-terminus, where the relative distances in the dimer
would be only affected by different conformations of the
linker between the N-terminal and TPR domains which
should be similar in both constructs. Moving further
away from the N-terminus, deletion of the C-terminal
domain is reflected in a lower dipolar frequency and
thus longer interspin distances (Fig. 6c). S197C is the
probe located furthest from the N-terminus, and in this
case, the deletion of the C-terminal domain results in
the abolition of almost all short-range interactions and a
significant increase of the interspin distance from 7.1 to
7.4 nm. Although efficiently labeled, S197C exhibits
shallow modulation depth upon deletion of the
C-terminal domain, suggesting that additional longer
distances, which are beyond our current resolution, may
be present. For the other two labeled positions, we
observe intermediate behavior; C153 shows similar re-
sults to S88C while the S136C position is more affected
by the C-terminal deletion, comparable to S197C
(Additional file 15: Figure S14). This is likely due to the
positions of both sites relative to the beginning of the
TPR. Although further along the primary sequence, in
the folded protein, C153 sits closer to the N-terminal
end of the TPR domain than S136 does. Thus, like
S88C, it is less affected by the deletion of the C-terminal
domain (Additional file 13: Figure S12).
When taken together, these native mass spectrometry,
SAXS, NMR relaxation, and EPR data evidence the
presence of a constrained conformation of full-length
SGTA in solution, where the C-terminal regions of both
monomers can interact to close the dimer at this end,
thereby bringing the two central TPR domains closer to-
gether and constraining their mobility (schematically
depicted in Fig. 7).
Discussion
To date, a complete structural characterization of
full-length SGTA remains inaccessible via traditional
methods (X-ray crystallography, NMR, cryo-EM), likely
due to the presence of flexible linkers between its dis-
tinct domains together with the challenging properties
of the C-terminal region. Our integrative approach, in
which we have combined several structural biology
(See figure on previous page.)
Fig. 6 SGTA C-terminal domain is able to dimerise in the full-length context II. a Calculated correlations times (τc) for N-terminal (blue) and TPR
(maroon) domains in the context of different SGTA constructs (n values and further data in Additional file 12: Figure S11). b Detail of 1H-15N
HSQC spectra for different SGTA constructs showing two amide signals from the N-terminal domain (blue) and two signals from the TPR domain
(maroon). Note severe broadening effect of TPR signals in FLΔQ and FL constructs. c DEER measurements and distances determined for FL and
NT-TPR SGTA constructs spin labeled in S88C and S197C mutants. (i) Primary frequency-domain DEER data. (ii) Background-corrected dipolar
evolution data (black lines) and corresponding fits obtained through DeerAnalysis2016 [49] by Tikhonov regularization. (iii) Distance distributions
obtained by Tikhonov regularization. Blue fits: FL SGTA; red fits: NT-TPR construct
Fig. 7 Speculative schematic representation of the hydrophobic
substrate recognition of SGTA. SGTA is well known to form a tight
dimer through its N-terminal domain. Here, we discovered that the
C-terminal region also dimerizes in a more transient or weak fashion,
facilitating the capture and/or shielding of hydrophobic substrates
such as the transmembrane helices of tail-anchored proteins. The
structural arrangement of this C-terminal dimer and its mechanism
of hydrophobic substrate binding are still a mystery and constitute
an open field for further research
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techniques, has now revealed significant insights into
the domain organization of SGTA in the context of the
full-length protein.
We find that SGTA is a multimodular protein whose
three domains are separated by two flexible, non-sequence
conserved, linkers thereby leaving these domains inde-
pendent from each other. The possibility of an independ-
ent motion of the TPR relative to the N-terminal domain
was first suggested for Sgt2, the fungal homolog of SGTA
[24]. Here, we have employed NMR (heteronuclear NOE
measurement), SAXS, and EPR, all of which support a
similar arrangement for SGTA which extends the model
to include C-terminal domain independence.
We have discovered that the C-terminal domain of
SGTA is partially structured: it contains one or two
α-helical regions, the NNP and likely the Q-rich
stretches, but, so far, the intrinsic properties of this do-
main preclude a typical high-resolution structural study.
In addition, our new data reveal that the C-terminal re-
gion exists as a dimer in solution as an excised domain
(direct detection by native mass spectrometry) and also
in the context of the full-length assembly (data from na-
tive mass spectrometry, SAXS, NMR relaxation, and
EPR experiments).
Whilst the exact nature of this C-terminal domain’s
folding and dimerization remains to be fully defined,
perturbation of the domain via deletion of the Q-rich re-
gion or mutation of the NNP motifs had effects on the
structure and/or function of the protein. We have ob-
served in vitro evidence suggesting that both conserved
regions are necessary for the correct folding/stability of
the domain. The comparison of NMR spectra between
CT and CTΔQ constructs shows large chemical shift dif-
ferences (Additional file 5: Figure S5); moreover, the
CTΔQ version is far less stable and more prone to
hydrogel formation than the complete C-terminal do-
main. These facts taken together indicate that the CTΔQ
construct is likely to be a structurally impaired protein
with a tendency towards aggregation. In addition, muta-
tion of the three NNP stretches affects the capacity of
the domain to interact with a putative ligand of ~370 Da
detected by mass spectrometry and reduces the stability
of the dimer in favor of higher aggregated states (Fig. 3d),
although it does not seem to significantly alter the sec-
ondary structure (Fig. 3a).
We also find that mutation of the NNP region alters the
effect of overexpressing SGTA in a well-established cell
culture model [12, 27], leading to the accumulation of a
model MLP substrate and its incorporation into cytosolic
aggresomes. The likely result of overexpressing a SGTA
variant unable to bind hydrophobic substrates would be
that steady-state MLP levels are similar to those observed
when the PEX19 control is overexpressed, but, on the
contrary, we observe a significant increase in OP91 with
the 3xNNP/AAA mutant. Hence, the mutation of the
NNP region may not abolish the capacity of SGTA to bind
to hydrophobic substrates, but rather alter its ability to re-
lease the substrate, inhibiting its access to the proteasome
and resulting in MLP accumulation. Alternatively, the
3xNNP/AAA mutation may result in a non-functional/
unstable aggregation prone form of exogenous SGTA that
titrates out endogenous quality control factors and
thereby delays the processing and degradation of MLPs.
In contrast, although the Q-rich region of SGTA has been
implicated in its binding to hydrophobic substrates [30],
the deletion of this region does not perceptibly perturb
the effects of its overexpression on OP91 when compared
to full-length SGTA.
We can only speculate about the structural arrange-
ment that the proposed helical regions may exhibit; the
importance of both the NNP and the Q-rich regions for
the protein stability indicates that they may participate
in the same fold and potentially cooperate to stabilize
the hydrophobic substrate. Furthermore, the lack of
NMR signals for the two unassigned stretches (one in
each of the NNP and Q-rich regions) might also reflect
their aggregation tendency and/or their capacity to bind
as yet unidentified molecules. We speculate that small
hydrophobic compounds or even short peptides (prob-
ably the molecules detected by mass spectrometry) may
be trapped by the C-terminal region during protein puri-
fication thereby creating a heterogeneous sample which
results in pronounced NMR chemical exchange in this
region. If this is the case, it is surprising that deleting
the Q-rich region had no statistically significant effect
on steady-state OP91 level in cells, while the same dele-
tion precluded binding of the small molecule as ob-
served by native MS.
Taken together all available data suggest that the NNP
region is essential for the correct functioning of the do-
main, and the Q-rich region is important for the correct
folding and stability of the domain and may be involved
in assisting substrate recognition.
The ability of SGTA to form a closed dimer conform-
ation has potential implications for its recognition of
hydrophobic substrates that will be a key area for future
investigation. At present, we can only speculate as to the
nature of substrate binding to SGTA. Since we only ob-
serve our bound molecule in dimerized C-terminal sam-
ples, it is tempting to speculate that an SGTA
C-terminal closing action might grab a substrate in a
tweezer-like motion, affording all round protection from
the aqueous cytoplasm (speculatively depicted in Fig. 7).
This would be comparable to the binding of hydropho-
bic TA proteins by Get3, where a single transmembrane
helix binds across the hydrophobic groove of Get3
formed by its dimer interface [19]. The “open” and
“closed” forms of Get3, which occur as a function of its
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nucleotide hydrolysis cycle, have been extensively char-
acterized at a structural level [34]. One of the Get3 heli-
ces was suggested to act as a dynamic “lid,” protecting
the transmembrane helices from aggregation during the
ER delivery process [17, 19]. Since TRC40 (human
equivalent of Get3), can receive TA proteins directly
from SGTA, the question remains as to how this hand-
over occurs. Unlike SRP54, a component of the signal
recognition particle, and TRC40, which both bind
comparable hydrophobic substrates, SGTA and BAG6
have no nucleotide binding or hydrolysis capability so
their mechanisms for substrate binding and release
remain unclear [32].
Nevertheless, the quality control machinery for
hydrophobic proteins in the mammalian cytoplasm
does appear to rely heavily on multimerisation [6] to
link and branch its components. In fact, the
SGTA_TPR domain is known to bind to Hsp90 and
Hsp70 chaperones, both of which can also form homo-
dimers which undergo conformational changes in con-
junction with their nucleotide hydrolysis cycles [35]. In
particular, Hsp90, like SGTA, has three domains with a
tight dimerization at one end and a transient
dimerization at the other, in combination with many
accessory proteins that bind along its length [36, 37].
Conclusions
We have established that SGTA can transiently dimerize
at its C-terminal in addition to its tight N-terminal
dimerization. This is a potential mechanism for it to sur-
round and protect its hydrophobic substrates (Fig. 7).
Our identification of the potential tweezer-like property
of SGTA adds important information to our gradually
increasing insights into its function and underlines the
importance of multimerization-dependent branching to
the interactions between factors that mediate intracellu-
lar protein quality control.
Methods
Cell-based studies
All reagents were from Sigma, unless stated otherwise.
Antibodies used were as follows: mouse anti-opsin [18],
rabbit anti-V5 (custom made), rabbit anti-V5 (Abcam),
and mouse anti-tubulin (gift from Keith Gull).
Fluorophore-conjugated secondary antibodies for micros-
copy and Western blotting were purchased from Molecu-
lar Probes and LI-COR Biosciences, respectively. The
plasmids for the expression of V5-tagged PEX19,
wild-type SGTA, and the TPR mutant were previously de-
scribed [12]. The 3x NNP/AAA (NNP positions at
226-228, 239-241 and 255-257) and ΔQ (Δ275-313) vari-
ants of SGTA-V5 were generated by multisite-directed
mutagenesis and inverse PCR, respectively, and validated
by DNA sequencing. HeLa cells were cultured in DMEM
supplemented with 10% FCS and 2 mM L-glutamine at
37 °C and 5% CO2. DNA transfections were performed
using Lipofectamine 2000 (Invitrogen) and cells analyzed
20–24 h post-transfection. The inducible HeLa cell line
expressing OP91 was generated using the Flp-In T-REx
system [12] and maintained in complete DMEM supple-
mented with 100 μg/ml hygromycin B and 4 μg/ml blasti-
cidin S at alternate passages. At 8 h after DNA
transfection, T-REx HeLa cells were treated with DMEM
containing 1 μg/ml tetracycline for an additional 12–16 h
to induce OP91expression. For Western blot analysis, cells
were lysed directly into SDS-PAGE sample buffer. Sam-
ples were denatured by 1 h incubation at 37 °C with shak-
ing, and then sonicated 3 × 15 s with the Bioruptor
(Diagenode). Proteins were separated by SDS-PAGE and
analyzed by infrared immunoblotting. The fluorescent
bands were visualized and quantified using Image Studio
(LI-COR Biosciences). For immunofluorescence micros-
copy, cells growing on coverslips were fixed with 3% (v/v)
formaldehyde, permeabilized with 0.1% (v/v) Triton
X-100, and washed with PBS in incubated with primary
and secondary antibodies in PBS at room temperature.
Coverslips were mounted in ProLong Diamond (Molecu-
lar Probes) and analyzed using an Olympus BX60 upright
microscope equipped with a MicroMax cooled, slow-scan
CCD camera (Roper Scientific) driven by Metaview soft-
ware (University Imaging Corporation). Images were proc-
essed using Adobe Photoshop CS5. Quantification results
are expressed as the mean ± s.e.m. from three independent
experiments. The statistical significance of the results was
assessed by applying a Student’s t test using Prism 7
(GraphPad). *P < 0.05, ** P < 0.01, *** P < 0.001.
DNA cloning and protein production
SGTA gene fragments encoding the following con-
structs: NT (1-86, including the linker), TPR (85-213),
NT-TPR (1-213), FLΔQ (1-274), TPR-CTΔQ (85-274),
CTΔQ (213-274), CT (213-313), and the FL SGTA
(1-313) were PCR amplified from cDNA (Life Technolo-
gies) and inserted into BamHI/XhoI restriction sites of a
home-modified pET28 vector, encoding an N-terminal
thioredoxin A fusion protein followed by a hexahistidine
tag and tobacco etch virus (TEV) protease cleavage site.
Typically, protein expression was carried out in BL21
(DE3) strains after induction with 0.5 mM isopropyl-
β-D-thiogalactopyranoside (IPTG) at OD600 ≈ 0.8,
followed by overnight incubation at 20 °C. For labeled
proteins, growth was carried out in M9 media supple-
mented with labeled ammonium chloride (> 98% 15N,
Sigma-Aldrich), glucose (> 99% U-13C, Sigma-Aldrich),
and/or 100% D2O (Sigma-Aldrich).
Harvested cells were resuspended in lysis buffer
(20 mM potassium phosphate, pH 8.0, 300 mM NaCl,
10 mM Imidazole, 250 μM TCEP), supplemented with
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protease inhibitors (0.3 μM Aprotinin, 10 μM Leupeptin,
and 1 μM Pepstatin A), and 1 mM PMSF and lysed by
sonication or cell disruptor (Constant Systems Ltd.). Cell
debris was removed by centrifugation, and the soluble
fractions were purified using nickel affinity chromatog-
raphy (HisTrapTM HP 5 ml, GE Healthcare) and eluted
with buffer containing 300 mM imidazole, followed by
dialysis into cleavage buffer (20 mM potassium phos-
phate, pH 8.0 and 300 mM NaCl) and digestion with
homemade TEV protease (≈ 100 μg/ml) at 4 °C over-
night. After removing the fusion protein and the histi-
dine tag by nickel affinity chromatography, the target
protein was recovered in the flow through and gel filtra-
tion steps were carried out using HiLoad 16/60 Super-
dex 200 column (GE Healthcare), previously equilibrated
in buffer containing 10 mM potassium phosphate pH
6.0, 100 mM NaCl and 250 μM TCEP. Proteins were
concentrated using Vivaspin concentrators (Sartorius
Stedin) and the sample purity and homogeneity was
assessed by SDS-PAGE and NMR.
Biochemical characterization
Analytical size-exclusion chromatography (SEC) was
performed using Superdex 200 10/300 GL column (GE
Healthcare) pre-equilibrated with 10 mM KPi, 100 mM
NaCl, pH 6.0 buffer. Molecular mass was estimated
based on the migration of protein standards on the SEC
column (aprotinin – 6.5 kDa, ribonuclease A –
13.7 kDa, carbonic anhydrase – 29.0 kDa, ovalbumin –
44.0 kDa, conalbumin – 75.0 kDa, and aldolase –
158.0 kDa; GE).
Circular dichroism (CD) spectra of CT, CT 3x NNP/
AAA and CTΔQ SGTA constructs were acquired using
an Aviv Circular Dichroism Spectrophotometer, Model
410 (Biomedical Inc., Lakewood, NJ, USA). Protein sam-
ples were adjusted to 0.5 mg/ml in 10 mM KPi, 100 mM
NaCl, and pH 6.0 buffer, and the experiments were re-
corded using a rectangular demountable Suprasil quartz
cell of 0.1 mm pathlength (Hellma Analytics). Each sam-
ple was scanned three times from 260 to 195 nm, at
1-nm intervals with an averaging time of 0.5 s. After
the background subtraction for all CD spectra, data
were converted to mean residue molar ellipticity and
deconvoluted using SELCON3 [38].
Dynamic light scattering (DLS) was performed using a
Nanosizer S diffraction particle sizer (Malvern Instru-
ments, UK) with a 5003 multi-digital correlator. The
light source was a 2 mW He-Ne laser, linearly polarized,
with λ = 633 nm, and scattering angle θ = 173°. Samples
were prepared at 0.5 mg/ml in 10 mM KPi, 100 mM
NaCl, and pH 6.0 buffer and loaded into 0.5 ml volume
disposable cuvettes (Sigma, Poole, UK). The experiments
were measured at room temperature in triplicate.
NMR
For NMR experiments, protein samples were prepared
at concentrations between 200 and 500 μM containing
10% D2O (Sigma-Aldrich) in 10 mM potassium phos-
phate pH 6.0, 100 mM NaCl, and 250 μM TCEP buffer
(supplemented with 10 μM DSS for proton chemical
shift referencing). All experiments were acquired in
5 mm NMR tubes at 25 °C using Bruker Avance spec-
trometers at 500, 700, or 950 MHz equipped with cryo-
probes and controlled by the TopSpin 3.1 software
package. Backbone assignments were carried out using
3D experiments (HNCO, HN(CA)CO, CBCA(CO)NH,
and CBCANH) [39] for CT, TPR-CTΔQ, and NT con-
structs (respective BMRB accession numbers: 27272,
27275, and 27276); assignment of the other constructs
was compiled using the same information. NMRPipe
[40] and CcpNMR Analysis [41] were used for spectral
processing and analysis.
Optimization
Since two stretches of peaks were missing from our
SGTA_CT spectra, we tested numerous conditions to
optimize the experiments and potentially reveal the
missing peaks. We produced a variety of different
SGTA_CT constructs, removing potentially aggregating
regions (CTΔQ) and adding the contiguous stable do-
main, TPR (TPR_CT and TPR_CTΔQ). For each of
these, we ran 1H-15N HSQC experiments at a range of
temperatures (Additional file 4: Figure S4), pH (6.0–8.9),
protein concentrations (10–500 μM), and with the
addition of detergents at various concentrations (DDM
or OG at 0.05–0.2%).
Relaxation
NMR relaxation experiments were performed for NT,
TPR, NT-TPR, TPR-CTΔQ, and FL constructs at con-
centrations between 200 and 400 μM. 15N - {1H} hetero-
nuclear measurements were obtained from the ratio of
crosspeak volumes between two experiments recorded
with 4 s of interscan delay (equilibrium) or 4 s of proton
saturation (saturated). A spectrum series with 30.8, 61.6,
123.2, 246.4, 369.6, 554.4, 739.2, 985.5, 1232, 1386, and
1540 ms of inversion-and-recovery delays and 16.96,
33.92, 50.88, 67.84, 84.8, 118.72, 152.64, 186.56, 220.48,
and 254.4 ms of CPMG echo delays was recorded for T1
and T2 measurements, respectively.
15N T1 and T2 relax-
ation times were computed using standard methods
analogous to previous approach [42], from the single ex-
ponential decay fitting of the peak intensities for each
amide signal. Correlation times (τc) have been estimated
from the T1/T2 averaged values for each domain (NT
comprising residues from 5 to 65 and TPR from 87 to
206) using the following equation:
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Values for n were as follows: NT = residues 5–65: in
construct NT, n = 57; in construct NT-TPR, n = 45; and in
construct FL, n = 37 and TPR = residues 87–205: in con-
struct TPR, n = 97; in construct NT-TPR, n = 81; in con-
struct TPR-CTΔQ, n = 92; and in construct FL n = 40.
Native mass spectrometry
Mass spectra of SGTA samples (NT-TPR, FLΔQ, FL,
CT, and CT 3x NNP/AAA mutant) were recorded on a
Synapt HD mass spectrometer (Waters) modified for
studying high masses. Protein samples were exchanged
into 0.20–0.75 M ammonium acetate (pH 7.0) solution
using Micro Bio–Spin 6 chromatography columns
(Bio-Rad) and diluted to a final concentration of 5–
10 μM before analysis. 2.5 μL of protein solution was
electrosprayed from a borosilicate emitter (Thermo Sci-
entific) for sampling. Typical conditions were capillary
voltage 1.8–2.5 kV, cone voltage 60–120 V, collision volt-
age 10–30 V, with backing pressure 3–4 mbar, and
source temperature of 20 °C. Spectra were calibrated ex-
ternally using cesium iodide. Data acquisition and pro-
cessing were performed using MassLynx 4.1.
SAXS
Small-angle X-ray scattering data were collected at the
EMBL beamline P12 at PETRA 3 storage ring (DESY,
Hamburg). All measurements were carried in 10 mM
KPi, 100 mM NaCl, pH 6.0, buffer at 25 °C with protein
solutions at concentrations ranging from 0.5 to 8.8 mg/
ml (for NT-TPR and FL SGTA). The experiments were
recorded using a PILATUS 2-M detector (DECTRIS,
Switzerland) at a sample-detector distance of 3.1 m and
a wavelength of λ = 0.12 nm, covering the range of mo-
mentum transfer 0.07 < s < 4.80 nm−1 (s = 4π sinθ/λ,
where 2θ is the scattering angle). The measurements
were taken in an in-vacuum capillary; no measurable ra-
diation damage was detected by comparison of 20 suc-
cessive frames with 50-ms exposures. The experimental
scattering profiles from all solutes were corrected for the
solvent scattering, normalized against transmitted inten-
sity and sample concentration, and processed using
standard protocols [43]. Extrapolation to infinite dilution
and merging of different data sets were performed with
PRIMUS [43]. The overall parameters such as radius of
gyration (Rg), the maximum particle dimension (Dmax),
and the Porod volume (Vp) were evaluated using stand-
ard procedures [43]. The program GNOM [44] was used
to calculate the distance distribution function. The mo-
lecular weight (MW) was estimated by comparing the
forward scattering with that of a standard protein (bo-
vine serum albumin).
The flexibility of the different constructs was compared
using the program EOM 2.0 [45]: EOM 2.0 is a program
that fits the averaged theoretical scattering intensity from
an ensemble of conformations into the experimental
SAXS data. A pool of n-independent models based upon
sequence and structural information was first generated.
Then, a genetic algorithm was performed for the selection
of the ensemble of conformations that best fit the data.
High-resolution structures for individual subunits, if avail-
able, were used as constraints for the generation of the
pool. Data were deposited in the SASBDB [46] under ac-
cession codes: SASDDB6 and SASDDC6.
TPR mutant design, spin labelling, and EPR sample
preparation
SGTA contains four cysteine residues (C38, C129, C148,
and C153), and to prepare the single cysteine mutants in
NT-TPR and FL SGTA constructs we first changed all
wild-type cysteine amino acids into serine residues using
site-directed mutagenesis. We confirmed that the folding
of the resultant cysteine-free protein is conserved using
NMR. Then, four positions were selected (S88, S136,
C153, and S197) to contain the solvent-exposed cysteine
for spin labeling. These different mutants were created
as well using site-directed mutagenesis (except in the
case of the wild-type C153). Proteins were prepared in
the same way as the wild-type versions.
Two milliliters of 0.25 mM SGTA (NT-TRP and FL
mutants) in 20 mM potassium phosphate and 300 mM
NaCl buffer at pH 8.0 were incubated with 150 μl of
37.8 mM (1-oxyl-2,2,5,5-tetramethylpyrroline-3-methyl)
methanethiosulfonate (MTSL, Santa Cruz Biotechnol-
ogy) spin label (~ 20-fold excess) overnight at 4 °C in the
dark. The spin label was removed by size-exclusion
chromatography using HiLoad 16/60 Superdex 200 col-
umn (GE Healthcare), previously equilibrated in buffer
containing 20 mM potassium phosphate pH 7.0 and
100 mM NaCl. Continuous-wave EPR spectra were ac-
quired on samples in the elution buffer, whereas PEL-
DOR samples were exchanged into D2O-containing
buffer (Sigma-Aldrich) before dilution with 50%
d8-glycerol (Sigma-Aldrich). The elution volume of each
labeled mutant following size-exclusion chromatography
was similar for all labeled proteins, indicating similar
stability of the mutants and the wild-type SGTA. To
make EPR samples (final concentration 300–500 μM), ~
200 μL of a given sample were transferred to a borosili-
cate glass tube (O.D. 5 mm, Wilmad 500 MHz
precision). Labeling efficiencies were above 70%, as de-
termined by continuous-wave EPR [47].
EPR spectroscopy
Continuous-wave EPR measurements were conducted at
room temperature on a Bruker E-scan bench top
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spectrometer, with 1-mW microwave power, 0.1-mT
modulation amplitude and 20-ms conversion time. After
flash freezing the samples in liquid nitrogen, DEER mea-
surements were performed at 50 K on an ELEXSYS
E500 spectrometer (Bruker) operating at 9.6 GHz
equipped with an ER 4118 X-MD5 resonator, a
cryogen-free close-circuit cryostat (Cryogenics Ltd.) and
a Lakeshore temperature controller. The four-pulse
double electron-electron resonance sequence [48] used
was π/2(νobs)-τl-π(νobs)-t-π(νpump)-(τl + τ2-t)-π(νobs)-τ2-e-
cho, where the observer pulse lengths were 16 and 32 ns
for the π/2 and π pulses, respectively. The pump pulse
length (π(νpump)) was 12 ns and τ2 was 7 or 8 μs. All
other parameters, namely τ1 = 400 ns and Δτ1 = 56 ns for
nuclear modulation averaging, were selected as de-
scribed earlier [48]. Data points were collected in 16 ns
time steps. The acquisition time for each DEER
spectrum was between 3 and 12 h. Time-domain spectra
were analyzed using the program DeerAnalysis2016 [49].
A homogeneous three-dimensional fit was used as back-
ground correction and the distance distributions com-
puted by Tikhonov regularization.
Additional files
Additional file 1: Figure S1. Sequence alignment of human SGTA
(Homo sapiens) and several homolog proteins: Sumatran orangutan
(Pongo abelii), white-cheeked gibbon (Nomascus leucogenys), dog (Cannis
lupus familiaris), pig (Sus scrofa), rat (Rattus norvegicus), chicken (Gallus
gallus), African clawed frog (Xenopus laevis), gray short-tailed opossum
(Monodelphis domestica), three-spined stickleback (Gasterosteus aculeatus),
Japanese pufferfish (Takifugu rubripes), American chameleon (Anolis
carolinensis), Spotted green pufferfish (Tetraodon nigroviridis), Japanese
rice fish (Oryzias latipes), and West Indian ocean coelacanth (Latimeria
chalumnae). All proteins were selected using the BLAST tool with the
hsSGTA sequence as query; the alignment was obtained using Jalview
2.7. (PDF 1115 kb)
Additional file 2: Figure S2. The SGTA-3xNNP/AAA-V5 mutant stimulates
the accumulation of OP91 in discrete cytosolic inclusions. HeLa cells stably
expressing OP91 under an inducible promoter were transiently transfected
with either a control plasmid (PEX19-V5) or plasmids encoding V5-tagged
SGTA variants as indicated, and then induced to express OP91. Cells were
fixed, stained for opsin and the V5 epitope, and analyzed by fluorescence
microscopy. Opsin-positive inclusions in SGTA-3xNNP/AAA-V5-expressing
cells are indicated by arrows. Scale bar is 10 μm. (PDF 19499 kb)
Additional file 3: Figure S3. SGTA-3xNNP/AAA-V5-expressing cells form
cytosolic inclusions in the absence of an MLP substrate. HeLa cells stably
expressing OP91 under an inducible promoter were transiently transfected
with plasmids encoding full-length or 3xNNP/AAA SGTA-V5. Uninduced cells
were fixed, stained for opsin and the V5 epitope, and analyzed by
fluorescence microscopy. V5-positive cytosolic inclusions were observed
exclusively in SGTA-3xNNP/AAA-V5 expressing cells. Scale bar is 10 μm.
(PDF 6818 kb)
Additional file 4: Figure S4. Overlaid 1H-15N HSQC spectra of TPR-
CTΔQ SGTA at a range of temperatures from 5 °C (gray-blue) to 40 °C
(maroon). (PDF 3684 kb)
Additional file 5: Figure S5. Complete analysis of the chemical shift
difference between SGTA constructs for the same backbone amide signal
in 1H-15N HSQC spectra. N-terminal, TPR, C-terminal, and other comparisons
appear in consecutive pages. (PDF 3505 kb)
Additional file 6: Figure S6. Chemical shift index analysis of full-length
SGTA, showing the alpha carbon and carbonyl chemical shift deviation
from random coil values. (PDF 571 kb)
Additional file 7: Figure S7. (A) Size-exclusion chromatography of
some different variants of SGTA. Note the unexpected elution volume of
the CT construct (red). (B) Dynamic light scattering intensity distributions
for CT and CTΔQ constructs showing the size of the most abundant
species (~ 9 nm diameter) and some aggregates (more populated in the
CTΔQ version). (C) Size-exclusion chromatography of the C-terminal
variants. The column utilized for panel C is different from panel A and
the calibration varies by ~ 1 ml. (PDF 80 kb)
Additional file 8: Figure S8. Mass spectrometry analysis of SGTA CT
construct, showing that the protein is not covalently modified. Expected
molecular weight = 10,877 Da. (PDF 2643 kb)
Additional file 9: Figure S9. Overlaid 1H-15N HSQC spectra of different
SGTA constructs under the same conditions. (A) SGTA FL (black), NT
(blue), TPR (red), and CT (green) proteins. (B) SGTA NT-TPR (black), NT
(blue), and TPR (red) constructs. (C) SGTA TPR-CTΔQ (black), TPR (red),
and CTΔQ (green) versions. (D) SGTA CT (black) and CTΔQ constructs
(green). (PDF 271 kb)
Additional file 10: Figure S10. 15N - {1H} heteronuclear NOE
measurements of different SGTA constructs; in all cases, the domain
boundaries and linker regions are similar. (PDF 142 kb)
Additional file 11: Table S1. Detailed SAXS data collection and derived
parameters for FL and NT-TPR constructs of SGTA. (DOCX 46 kb)
Additional file 12: Figure S11. 15N NMR relaxation analysis of N-
terminal (A) and TPR (B) domains in different SGTA constructs. NT =
residues 5–65: in construct NT, n = 57; in construct NT-TPR, n = 45; and in
construct FL, n = 37. TPR = residues 87–205: in construct TPR, n = 97; in
construct NT-TPR, n = 81; in construct TPR-CTΔQ, n = 92; and in construct
FL n = 40. Boxplots show the T1 and T2 values obtained for residues of
each domain presenting the median, the interquartile range (colored
boxes), the maximum and minimum values (segments with whiskers),
and the outliers (dots); the correlation times (shown above) were
calculated using the averaged value and the standard deviation as set in
the “Methods” section. (PDF 4187 kb)
Additional file 13: Figure S12. Selected mutations in the TPR domain
for MTSL labelling in the EPR experiments. (A) Cartoon representation of
the TPR domain with the four positions depicted as green balls. (B)
Surface representation of the TPR domain with the four residues colored
in green. Notice that the S136C mutation is inside the TPR groove.
(PDF 129 kb)
Additional file 14: Figure S13. CW-EPR spectra of the FL and C-
terminal deleted (NT-TPR) SGTA proteins. Room Temperature CW-EPR
spectra for SGTA FL mutants (blue lines) and corresponding NT-TPR
constructs (red lines). CW-EPR spectra mainly provide information about
the mobility of the spin labels and thus about the local environment of
the labeled residues. Spectra of the FL protein are slightly broader than
those corresponding to the C-terminal deletion (NT-TPR), as highlighted
by arrows in the figure, suggesting that the absence C-terminal domain
increase the overall mobility of the TPR domain. (PDF 559 kb)
Additional file 15: Figure S14. DEER measurements and distances
determined for FL and NT-TPR SGTA constructs spin-labeled in the four
SGTA mutants. (i) Primary frequency-domain DEER data. (ii) Background-
corrected dipolar evolution data (black lines) and corresponding fits
obtained through DeerAnalysis2016 [49] by Tikhonov regularization. (iii)
Distance distributions obtained by Tikhonov regularization. Blue fits: FL
SGTA; red fits: NT-TPR construct. (PDF 3125 kb)
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